SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 156,864 shares at $25.77 ($4.1M) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Open-market sale of $4.1M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.77 | 26,800 | $691K | 16.7% |
| 2 | $26.14 | 52,250 | $1.4M | 33.0% |
| 3 | $26.81 | 38,907 | $1.0M | 25.2% |
| 4 | $26.81 | 38,907 | $1.0M | 25.2% |
| Total | $26.41 avg | 156,864 | $4.1M | 100% |
| Filing → |
| VIR | SELL | 2025-10-24 | $3.6M | — | Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |